Evidence map›Paper›PMID 39591157›Full record

ArticleVaccines2024

Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination.

Angela Domínguez, Ana Avellón, Victoria Hernando, Núria Soldevila, Eva Borràs, Ana Martínez, Conchita Izquierdo, Núria Torner, Carles Pericas, Cristina Rius and 1 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Angela DomínguezDepartment of Medicine, Universidad de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-0219-1907
Ana AvellónCIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-4425-6350
Victoria HernandoCentro Nacional de Epidemiología, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Núria SoldevilaDepartment of Medicine, Universidad de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-1353-5325
Eva BorràsDepartment of Medicine, Universidad de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-3859-9907
Ana MartínezCIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Conchita IzquierdoAgència de Salut Pública de Catalunya, 08005 Barcelona, Spain.ORCID 0000-0003-2611-6055
Núria TornerDepartment of Medicine, Universidad de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0003-0143-5295
Carles PericasDepartment of Medicine, Universidad de Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-6481-452X
Cristina RiusCIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Pere GodoyCIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-2896-7286

Funding

Programme of Prevention, Surveillance, and Control of Transmissible Diseases (PREVICET), CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid ESPCP43
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cirrhosishepatitis Bhepatocellular carcinomaimpact evaluationvaccination

Identifiers

PMID39591157
PMCPMC11598889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.